Stocks and Investing
Stocks and Investing
Fri, May 6, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Thu, May 5, 2022
[ 12:00 AM ] - WOPRAI
Charles Zhu Upgraded (ZYME) to Strong Buy and Held Target at $14 on, May 5th, 2022
Charles Zhu of Guggenheim, Upgraded "Zymeworks Inc." (ZYME) to Strong Buy and Held Target at $14 on, May 5th, 2022.
Charles has made no other calls on ZYME in the last 4 months.
There are 3 other peers that have a rating on ZYME. Out of the 3 peers that are also analyzing ZYME, 0 agree with Charles's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Charles
- Josh Schimmer of "Evercore ISI Group" Initiated at Buy and Held Target at $15 on, Tuesday, March 15th, 2022
- Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $30 on, Monday, February 28th, 2022
- Jim Birchenough of "Wells Fargo" Maintained at Buy with Decreased Target to $48 on, Wednesday, February 9th, 2022
Contributing Sources